Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
CD8-mediated inflammatory central nervous system disorders.
A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Scoring treatment response in patients with relapsing multiple sclerosis.
Advanced diffusion MRI fiber tracking in neurosurgical and neurodegenerative disorders and neuroanatomical studies: A review.
Multiple sclerosis and vitamin D during pregnancy and lactation.
[New therapies in multiple sclerosis].
B-cell enrichment and epstein-barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis.
Patient adherence to and tolerability of self-administered interferon β-1a using an electronic autoinjection device: a multicentre, open-label, phase IV study.
Aggregation of MBP in chronic demyelination.
Cognitive performance of neuromyelitis optica patients: comparison with multiple sclerosis.
Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
Cognitive but not affective theory of mind deficits in mild relapsing-remitting multiple sclerosis.
Interleukin-2 and the brain: dissecting central versus peripheral contributions using unique mouse models.
Versatility of the complement system in neuroinflammation, neurodegeneration and brain homeostasis.
Measurement and clinical effect of grey matter pathology in multiple sclerosis.
Understanding Tremor in Multiple Sclerosis: Prevalence, Pathological Anatomy, and Pharmacological and Surgical Approaches to Treatment.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Atomic view of a toxic amyloid small oligomer.
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study.
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosis.
HERVs in neuropathogenesis.
Poster abstracts from the third international symposium on gait and balance in multiple sclerosis: selecting the right measures.
In vivo detection of experimental optic neuritis by pupillometry.
Interventions to evaluate fitness to drive among people with chronic conditions: Systematic review of literature.
Pages
« first
‹ previous
…
207
208
209
210
211
212
213
214
215
…
next ›
last »